| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 640212 | Null | 0.0174563696971638 | -0.18538343 |
| NSC 641176 | Null | 0.0174563696971638 | -0.2865776 |
| NSC 671806 | Null | 0.0174563696971638 | 0.0066579681 |
| NSC 713750 | Null | 0.0174563696971638 | 0.078269589 |
| NSC 605756 | Null | 0.0187206825450445 | 0.06133208 |
| NSC 633530 | 1H-Pyrido[3,4-b]indol-1-one, 2,3,4,9-tetrahydro-2-[4-(4- phenyl-1-piperazinyl)butyl]-9-methyl- | 0.0187206825450445 | -0.060021911 |
| NSC 690271 | ANTINEOPLASTIC-690271 | 0.0187206825450445 | 0.026186051 |
| NSC 703111 | Null | 0.0187206825450445 | 0.44174809 |
| NSC 706190 | 6H,14H-Benzo[b]naphtho[2,3-f][1,5]dithiocin-6,14-dione, 2-bromo- | 0.0187206825450445 | -0.078475692 |
| NSC 753190 | 3,5-dichloro-N-(4-(3-(4-chloro-3-hydroxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)benzamide | 0.0187206825450445 | -0.13843146 |